<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03516721</url>
  </required_header>
  <id_info>
    <org_study_id>CICO-001</org_study_id>
    <nct_id>NCT03516721</nct_id>
  </id_info>
  <brief_title>Chronotropic Incompetence During Exercise in Obese Adolescents: Clinical Implications and Pathophysiology</brief_title>
  <acronym>CICO</acronym>
  <official_title>Chronotropic Incompetence During Exercise and Relations With Development of Cardiovascular Disease in Obese Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hasselt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jessa Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hasselt University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A reduction in peak heart rate (HR) and suppressed HR response during exercise is highly
      prevalent in obese populations. This phenomenon is also known as chronotropic incompetence
      (CI). In adult obese individuals, CI is independently related to elevated risk for major
      adverse cardiovascular events and premature death. Despite the established association
      between CI and prognosis in adult populations, the prognostic relevance of CI in adolescents
      with obesity has however deserved no attention, but is important. CI during exercise testing
      may indicate various, yet undetected anomalies, such as altered blood catecholamine and/or
      potassium concentrations during exercise, structural myocardial abnormalities or ventricular
      stiffness, impaired baroreflex sensitivity and cardiovascular autonomic dysfunction,
      atherosclerosis, or cardiac electrophysiological anomalies, which all have been detected in
      obese children and adolescents. However, whether CI during exercise testing may be a
      sensitive and specific indicator for these anomalies in obese adolescents has not been
      studied yet. In addition, the exact physiology behind obesity and development of heart
      disease remains to be studied in greater detail in obese adolescents. In this project, we
      examine the prevalence of CI (during maximal cardiopulmonary exercise testing, CPET) in 60
      obese adolescents (aged 12-16 years) vs. 60 lean adolescents, and study the association
      between CI and changes in CPET parameters, lactate, catecholamine and potassium
      concentrations during CPET, biochemical variables, and cardiac electrophysiology (by ECG
      recording). In addition, the relation between CI and cardiac function (echocardiography) will
      be examined in a subgroup (29 lean and 29 obese) of these adolescents. In this regard, the
      diagnostic value of HR (responses) during maximal exercise testing will be clarified in obese
      adolescents, and the physiology behind the elevated risk for heart disease in obese
      adolescents can be explored.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2016</start_date>
  <completion_date type="Actual">July 1, 2017</completion_date>
  <primary_completion_date type="Actual">May 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Heart rate (HR)</measure>
    <time_frame>day 1</time_frame>
    <description>Assessed using a 12-lead ECG device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ventilatory function</measure>
    <time_frame>day 1</time_frame>
    <description>Determined during maximal cardiopulmonary exercise testing.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>height</measure>
    <time_frame>day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>weight</measure>
    <time_frame>day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PAQ-A (Physical Activity Questionaire for Adolescents)</measure>
    <time_frame>day1</time_frame>
    <description>physical activity determined using the validated Dutch physical activity questionnaire for adolescents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tanner scale</measure>
    <time_frame>day 1</time_frame>
    <description>Puberty stage (ranging from 1 to 5) will be assessed in all participants by the pediatric endocrinologist using Tanner staging criteria.
Boys - development of external genitalia Girls - breast development Boys and girls - pubic hair</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma glucose</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>iron</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>aspartate aminotransferase</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>alanine aminotransferase</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gamma-glutamyl transpeptidase</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>alkaline phosphatase</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>uric acid</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>calcium</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood total cholesterol</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>high-density lipoprotein cholesterol</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>low-density lipoprotein cholesterol</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>proteins</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>triglyceride concentrations</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>c-reactive proteine</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>thyroid-stimulating hormone</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>free thyroxine</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cortisol and serum insulin</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum leptin concentration</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood haemoglobin</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>haematocrit</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>leukocytes</measure>
    <time_frame>day 1</time_frame>
    <description>blood analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiography</measure>
    <time_frame>day 1</time_frame>
    <description>Assessment left ventricular structure and systolic and diastolic function</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Obesity</condition>
  <condition>Adolescent Obesity</condition>
  <arm_group>
    <arm_group_label>Obese adolescents</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lean adolescents</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>the prevalence of chronotropic incompetence CI during maximal cardiopulmonary exercise testing, CPET</intervention_name>
    <arm_group_label>Obese adolescents</arm_group_label>
    <arm_group_label>Lean adolescents</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged 12-16 years

          -  obese or lean (based on extended international (IOTF) body mass index cut-offs for
             thinness, overweight and obesity)

          -  Parental permission

        Exclusion Criteria:

        - Chronic cardiovascular, renal, pulmonary and orthopedic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique Hansen, prof. dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hasselt University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jessa Ziekenhuis</name>
      <address>
        <city>Hasselt</city>
        <zip>3500</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2018</study_first_submitted>
  <study_first_submitted_qc>May 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2018</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hasselt University</investigator_affiliation>
    <investigator_full_name>Dominique Hansen</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Pediatric Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

